Effects of danazol and progesterone on sex hormone-binding globulin mRNA expression in human endometrial cancer cell line Ishikawa

[1]  T. Tamaya,et al.  Expression of sex hormone-binding globulin mRNA in human endometrial cancers , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  T. Tamaya,et al.  Sex hormone-binding globulin mRNA levels in human uterine endometrium. , 1994, European journal of endocrinology.

[3]  G. Chetrite,et al.  Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  J. V. Vanden Heuvel,et al.  Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. , 1993, BioTechniques.

[5]  J. Pasqualini,et al.  Effect of the progestagen R5020 (promegestone) and of progesterone on the uptake and on the transformation of estrone sulfate in the MCF-7 and T-47d human mammary cancer cells: correlation with progesterone receptor levels. , 1992, Cancer letters.

[6]  A. Purohit,et al.  Inhibition of oestrogen synthesis in postmenopausal women with breast cancer , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  E. Baulieu,et al.  Effects of hormones on SBP mRNA levels in human cancer cells , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  R. Coombes,et al.  Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  D. Apter,et al.  Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate. , 1990, European journal of obstetrics, gynecology, and reproductive biology.

[10]  H. Honjo,et al.  Estrone sulfate and sulfatase activity in human breast cancer and endometrial cancer. , 1989, Journal of steroid biochemistry.

[11]  K. Matsumoto,et al.  Growth inhibition by danazol in a human endometrial cancer cell line with estrogen-independent progesterone receptors. , 1987, Journal of steroid biochemistry.

[12]  C. Cheng,et al.  The cDNA‐deduced primary structure of human sex hormone‐binding globulin and location of its steroid‐binding domain , 1987, FEBS letters.

[13]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[14]  M. Dowsett,et al.  The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. , 1987, British Journal of Cancer.

[15]  K. Matsumoto,et al.  Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro. , 1986, American journal of obstetrics and gynecology.

[16]  M. Williams,et al.  A controlled trial of danazol in the treatment of multiple recurrent breast cysts , 1986, The British journal of clinical practice.

[17]  R. Vihko,et al.  Short-Term Effects of Tamoxifen, Medroxyprogesterone Acetate, and Their Combination on Receptor Kinetics and 17β-Hydroxysteroid Dehydrogenase in Human Endometrium , 1985, Obstetrics and gynecology.

[18]  D. Sleijfer,et al.  Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer. , 1985, Cancer treatment reports.

[19]  M. Nishida,et al.  [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors]. , 1985, Nihon Sanka Fujinka Gakkai zasshi.

[20]  G. Avvakumov,et al.  A recognition system for sex-hormone-binding protein-estradiol complex in human decidual endometrium plasma membranes. , 1984, Biochimica et biophysica acta.

[21]  G. Rannevik,et al.  Short‐term effects of danazol on endometrial histology , 1984, Acta obstetricia et gynecologica Scandinavica. Supplement.

[22]  O. Jänne,et al.  Danazol has progestin-like actions on the human endometrium. , 1982, Acta endocrinologica.

[23]  W. Dmowski,et al.  Endocrine properties and clinical application of danazol. , 1979, Fertility and sterility.

[24]  E. Kohorn.  Gestagens and endometrial carcinoma. , 1976, Gynecologic oncology.

[25]  D. Decker,et al.  Progestogen treatment of recurrent endometrial carcinoma. , 1971, American journal of obstetrics and gynecology.

[26]  T. Tamaya,et al.  Levels of sex hormone-binding globulin (SHBG) and corticosteroid-binding globulin (CBG) messenger ribonucleic acid (mRNAs) in ovarian endometriosis. , 1995, Reproduction, nutrition, development.

[27]  J. Pasqualini,et al.  Importance of estrogen sulfates in breast cancer. , 1989, Journal of steroid biochemistry.

[28]  H. Fujita,et al.  Effect of medroxyprogesterone acetate on secondary spreading of endometrial cancer. , 1989, Invasion & metastasis.

[29]  H. Fujita,et al.  Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. , 1989, Invasion & metastasis.

[30]  E. Baulieu,et al.  Cellular distribution and hormonal regulation of h-SBP in human hepatoma cells. , 1987, Journal of steroid biochemistry.

[31]  R. Cleary,et al.  Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications. , 1981, American journal of obstetrics and gynecology.

[32]  M. Cohen,et al.  Antigonadotropin (danazol) in the treatment of endometriosis. Evaluation of posttreatment fertility and three-year follow-up data. , 1978, American journal of obstetrics and gynecology.